Singapore markets closed

KYMR Jun 2024 12.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.70000.0000 (0.00%)
As of 10:30AM EDT. Market open.
Full screen
Previous close0.7000
Open0.7000
Bid0.0000
Ask0.0000
Strike12.50
Expiry date2024-06-21
Day's range0.7000 - 0.7000
Contract rangeN/A
Volume1
Open interest1
  • GlobeNewswire

    Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting

    KT-333 demonstrated initial clinical proof of concept across multiple hematological malignancies, including complete responses in two patients with Hodgkin’s lymphoma Robust STAT3 knockdown and positive immunomodulatory effect achieved in blood and tumor KT-333 was well-tolerated with Phase 1 dose escalation ongoing and additional data expected in the second half of 2024 WATERTOWN, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutic

  • GlobeNewswire

    Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting

    KT-253 demonstrates initial clinical proof of concept in patients with tumor types shown to be sensitive in preclinical models, including responses in MCC and AML Evidence of target engagement and potent upregulation of p53 pathway biomarkers even at the lowest dose levels in solid tumor and AML patients KT-253 was generally well tolerated without hematologic adverse events seen with traditional MDM2 small molecule inhibitors KT-253 Phase 1 study ongoing with additional data expected in the seco

  • GlobeNewswire

    Kymera Therapeutics to Participate in Upcoming June Investor Conferences

    WATERTOWN, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events: Jefferies 2024 Global Healthcare Conference in New York, NY on June 5 at 11:30 a.m. ET; andGoldman Sachs 45th Annual Global Healthcare Conference in Miami, FL on